BPG is committed to discovery and dissemination of knowledge
Articles in Press
9/13/2019 3:59:50 AM | Browse: 132 | Download: 97
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 49558
Country/Territory China
Category Oncology
Manuscript Type Retrospective Cohort Study
Article Title Revisiting oral fluoropyrimidine with cetuximab in metastatic colorectal cancer: Real-world data in Chinese population
Manuscript Source Unsolicited Manuscript
All Author List Ka-On Lam, Man-Chi Fu, Kin-Sang Lau, Kam-Mo Lam, Cheuk-Wai Choi, Wan-Hang Chiu, Cheng-Man Yuen, Lai-Han Kwok, Fong-Kit Tam, Wing-Lok Chan, Sum-Yin Chan, Pui-Ying Ho, To-Wai Leung and Ho‐Fun Lee
Funding Agency and Grant Number
Corresponding Author Ka-On Lam, MBBS, Assistant Professor, Clinical Oncology, The University of Hong Kong, 1/F, Professorial Block, Queen Mary Hospital 102 Pokfulam Road, Hong Kong NA, Hong Kong, China. lamkaon@hku.hk
Key Words Capecitabine; 5-Fluorouracil; Cetuximab; Metastatic colorectal cancer; Chinese;
Core Tip Cetuximab in combination with oral fluoropyrimidine (FP) remains controversial in metastatic colorectal cancer. A retrospective cohort analysis was performed to compare oral FP with infusional FP in combination with cetuximab in Chinese population in the real-world setting. Our analysis demonstrated comparable efficacy and safety profiles of cetuximab in combination with both oral and infusional FP. Thus, oral FP-based chemotherapy should be considered as a valid option in Chinese patients receiving cetuximab.
Citation Lam KO, Fu MC, Lau KS, Lam KM, Choi CW, Chiu WH, Yuen CM, Kwok LH, Tam FK, Chan WL, Chan SY, Ho PY, Leung TW, Lee HF. Revisiting oral fluoropyrimidine with cetuximab in metastatic colorectal cancer: Real-world data in Chinese population. World J Gastrointest Oncol 2019; 11(11): 1031-1042
Received
2019-06-04 01:45
Peer-Review Started
2019-06-06 10:32
To Make the First Decision
2019-08-28 05:24
Return for Revision
2019-08-30 03:14
Revised
2019-09-07 06:37
Second Decision
2019-09-12 10:28
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2019-09-13 03:59
Articles in Press
2019-09-13 03:59
Publication Fee Transferred
Edit the Manuscript by Language Editor
2019-09-24 10:22
Typeset the Manuscript
2019-10-23 02:07
ISSN 1948-5204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com